Chongqing Zhifei Stock Hits Day Low Amid Price Pressure at CNY 12.20

Chongqing Zhifei Biological Products Co., Ltd. experienced a notable decline today, with the stock dropping by 3.17% and reaching an intraday low of CNY 12.20. This performance stands in contrast to the China Shanghai Composite, which saw a modest decrease of 0.43% on the same day. Over the past week, Chongqing Zhifei has recorded a decline of 1.21%, while its performance over the last month reflects a significant drop of 17.5%. Year-to-date, the stock has fallen by 35.29%, and its one-year performance shows a stark decrease of 36.41%. The three-year and five-year performance metrics are particularly concerning, with declines of 73.59% and 93.21%, respectively. The company's financial health is under scrutiny, as it has reported negative results for ten consecutive quarters. Recent figures indicate a 4.06% drop in net sales, with a staggering annual rate of -11.88% in net sales growth over the past five years. The current market capitalization stands at CNY 16,947 million, and the stock is characterized by a high dividend yield of 0%. These trends highlight the ongoing challenges faced by Chongqing Zhifei in the competitive pharmaceuticals and biotechnology sector.